- Home
- / Sitryx
Sitryx
Total Funding
$30 M
Sitryx Summary
Company Summary
- Overview
- Sitryx is a biopharmaceutical company focused on regulating cell metabolism. It develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.
- Type
- Private
- Status
- Active
- Founded
- 2018
- HQ
- Oxford, GB | view all locations
- Website
- http://www.sitryx.com/
- Cybersecurity rating
Table of Contents
Key People
Pierre Legault, Board Chairman
Patrik Foerch, Head of Biology
Paul-Peter Tak, Founder, Independent Director
LocationsView all
2 locations detected
Oxford, England HQ
United Kingdom
Magdalen Centre, Robert Robinson Ave
London, England
United Kingdom
71 Kingsway, Holborn